Rain Oncology

📍 Newark, United States🗓 Founded 2017👥 36 employees💰 Last funded May 2018
Biotechnology Research🌐 rainoncology.com
Website LinkedIn
Rain Oncology is a clinical-stage company researching, developing and translating innovative targeted therapies for patients with cancer to help provide them hope to get their lives back. Our therapies target oncogenic drivers to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Investor activity2017–2018 · investors recorded per year
2017120182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Rain Oncology?
Rain Oncology has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Rain Oncology last raise funding?
The most recent investment in Rain Oncology recorded on gritt.io was in May 2018.
When was Rain Oncology founded?
Rain Oncology was founded in 2017.
What industry is Rain Oncology in?
Rain Oncology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Rain Oncology based?
Rain Oncology is headquartered in Newark, United States.